Emerging mechanisms for exercise effects on muscle wasting and anabolic resistance

J. William Deaver; Nicholas P. Greene

doi:10.1016/j.smhs.2020.11.001

Sports Medicine and Health Science ›› 2020, Vol. 2 ›› Issue (4) : 175 -176. DOI: 10.1016/j.smhs.2020.11.001

Original article

Emerging mechanisms for exercise effects on muscle wasting and anabolic resistance

J. William Deaver ¹^,²
, Nicholas P. Greene

Author information +

History +

PDF

Cite this article

Download citation ▾

J. William Deaver, Nicholas P. Greene. Emerging mechanisms for exercise effects on muscle wasting and anabolic resistance. Sports Medicine and Health Science, 2020, 2(4): 175-176 DOI:10.1016/j.smhs.2020.11.001

登录浏览全文

4963

注册一个新账户忘记密码

Authors’ contributions

All contributing authors are represented in the list of authors appearing on the manuscript, and all authors approve of this manuscript and agree with submission for consideration of publication in Sports Medicine and Health Science.

Funding

Work presented here was funded by National Institutes of Health under Award Number R01AR075794 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Conflict of interest

The authors declare to no conflicts of interest that could influence the interpretations of this work.

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Cancer facts & figures 2020 \| American cancer society.

[2]	J.L. Brown, M.E. Rosa-Caldwell, D.E. Lee, et al.. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice. J Cachexia Sarcopenia Muscle, 8 (6) ( 2017), pp. 926-938, DOI: 10.1002/jcsm.12232

[3]	K.C.H. Fearon, D.J. Glass, D.C. Guttridge. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metabol, 16 (2) ( 2012), pp. 153-166, DOI: 10.1016/j.cmet.2012.06.011

[4]	J.K. Onesti, D.C. Guttridge. Inflammation based regulation of cancer cachexia. BioMed Res Int, 2014 ( 2014), DOI: 10.1155/2014/168407

[5]	K. Fearon, F. Strasser, S.D. Anker, et al.. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol, 12 (5) ( 2011), pp. 489-495, DOI: 10.1016/S1470- 2045(10)70218-7

[6]	J.P. Hardee, B.R. Counts, J.A. Carson. Understanding the role of exercise in cancer cachexia therapy. Am J Lifestyle Med, 13 (1) ( 2019), pp. 46-60, DOI: 10.1177/1559827617725283

[7]	T.S. Solheim, B.J.A. Laird, T.R. Balstad, et al.. Cancer cachexia: rationale for the MENAC (Multimodal—exercise, nutrition and anti-inflammatory medication for cachexia) trial. BMJ Support Palliat Care, 8 (3) ( 2018), pp. 258-265, DOI: 10.1136/bmjspcare-2017-001440

[8]	T.S. Solheim, B.J.A. Laird, T.R. Balstad, et al.. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle, 8 (5) ( 2017), pp. 778-788, DOI: 10.1002/jcsm.12201

[9]	E.J. Roeland, K. Bohlke, V.E. Baracos, et al.. Management of cancer cachexia: ASCO guideline. J Clin Oncol, 38 (21) ( 2020), pp. 2438-2453, DOI: 10.1200/JCO.20.00611